Dr. Schaider Discusses Drug Resistance for Melanoma
Helmut Schaider, MD, associate professor, Dermatology Research Centre, the University of Queensland, discusses adaptive drug resistance for patients with melanoma.
According to Schaider, adaptive drug resistance occurs at the beginning of treatment. Drug resistance generally occurs in the first 3 to 6 weeks.
More studies need to be conducted to determine why the cells become resistant to certain treatments, states Schaider.